Ramtin Agah
Chief Medical Officer at RenovoRx Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: RenovoRx Inc., 3 years.
RenovoRx Inc.
Director · Chief Medical Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | RenovoRx Inc. | Open-market purchase | +10,000 | $1.00 | $10,000 |
| Dec 31, 2025 | RenovoRx Inc. | Open-market purchase | +9,795 | $0.86 | $8,424 |
| Dec 30, 2025 | RenovoRx Inc. | Open-market purchase | +205 | $0.83 | $170 |
| Dec 16, 2025 | RenovoRx Inc. | Open-market purchase | +12,000 | $0.85 | $10,200 |
| Dec 5, 2025 | RenovoRx Inc. | Open-market purchase | +10,000 | $0.96 | $9,600 |
| Nov 24, 2025 | RenovoRx Inc. | Open-market purchase | +12,000 | $0.80 | $9,600 |
| Nov 21, 2025 | RenovoRx Inc. | Open-market purchase | +10,000 | $0.80 | $8,000 |
| Jun 5, 2025 | RenovoRx Inc. | Open-market purchase | +21,000 | $1.40 | $29,400 |
| Apr 22, 2025 | RenovoRx Inc. | Gift | −400,000 | — | — |
| Apr 15, 2025 | RenovoRx Inc. | Open-market purchase | +15,000 | $0.90 | $13,500 |
| Apr 11, 2025 | RenovoRx Inc. | Open-market purchase | +20,000 | $0.80 | $16,000 |
| Apr 9, 2025 | RenovoRx Inc. | Open-market purchase | +30,000 | $0.81 | $24,300 |
| Apr 8, 2025 | RenovoRx Inc. | Open-market purchase | +26,000 | $0.84 | $21,840 |
| Jan 26, 2024 | RenovoRx Inc. | Open-market purchase | +40,983 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.